EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Performance evaluation of the LIOFeron®TB/LTBI IGRA for screening of paediatric LTBI and tuberculosis

Chiara Della Bella, Marco Antonio Motisi, Elisabetta Venturini, Sofia D'Elios, Evangelia Asvestopoulou, Agnese Maria Tamborino, Luisa Galli, Mario Milco D'Elios, Elena Chiappini

European Journal of Pediatrics · 2025

DOI: 10.1007/s00431-025-05972-6 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Pediatrics, 2025. Verfasst von Chiara Della Bella und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular and Developmental Medicine, University of Siena, Siena, Italy. Hauptthemen laut MEDLINE: Latent Tuberculosis, Interferon-gamma Release Tests, Mass Screening. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Università degli Studi di Siena.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

High-accuracy diagnostic screening tests for Mycobacterium tuberculosis (MTB) infection are required, primarily to detect patients with latent infections (LTBIs) in order to avoid their progression to active tuberculosis disease. The performance of the novel IGRA LIOFeron®TB/LTBI was evaluated in children. The originality of this test is the new MTB antigen contained ( l -alanine dehydrogenase), identified as a tool to differentiate active TB from LTBI infection.

Methods

From March 2022 to November 2023, a population of 90 children was enrolled and grouped into healthy, active TB or LTBI individuals, based on diagnostic guidelines. The blood of all these participants was tested with LIOFeron®TB/LTBI assay in comparison to diagnosis, as gold standard, and to the current used IGRA QuantiFERON®-TB Gold Plus.

Results

The two assays demonstrated an excellent concordance of their results with patients’ diagnosis of MTB infection. The performance of LIOFeron®TB/LTBI assay in terms of accuracy of MTB infection diagnosis was high at ROC analysis (AUC = 0.997), and the test showed 100% sensitivity in LTBI detection. The QuantiFERON®-TB Gold Plus sensitivity for LTBI detection was 85.7%.

Conclusions

Based on the obtained results, the LIOFeron®TB/LTBI assay appears to be a promising test for TB and LTBI screening among paediatric patients. What is known: • The detection of LTBI in children, exposed to MTB infections, followed by appropriate treatment, has a pivotal role in reducing tuberculosis burden. • IGRA tests are easy-to-use methods for helping large TB screening in paediatrics. What is new: • The LIOFeron®TB/LTBI performance evaluation showed 100% of sensitivity in the detection of LTBI patients. • The LIOFeron®TB/LTBI assay might be useful for the detection of LTBI and active tuberculosis paediatric patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Latent TuberculosisInterferon-gamma Release TestsMass ScreeningHumansChildMaleFemaleSensitivity and SpecificityChild, PreschoolAdolescentMycobacterium tuberculosisAntigens, BacterialInfantROC Curve

Stichwörter der Autor:innen

Mycobacterium tuberculosisAlanine dehydrogenaseDiagnosisInterferon-gamma release assayTuberculosis

Substanzen

Antigens, Bacterial

Autor:innen und Institutionen

  • Department of Molecular and Developmental Medicine, University of Siena, Siena, Italy.
  • Paediatrics resident, Department of Health Sciences, Anna Meyer Children's University Hospital, University of Florence, Florence, Italy.
  • Infectious Diseases Unit, Department of Health Sciences, Anna Meyer Children's University Hospital, University of Florence, Florence, Italy.
  • Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
  • Department of Molecular and Developmental Medicine, University of Siena, Siena, Italy. delios@unisi.it.

Förderung

  • Università degli Studi di Siena

Zitieren

APA

Della Bella, C., Motisi, M. A., Venturini, E., D'Elios, S., Asvestopoulou, E., Tamborino, A. M., Galli, L., D'Elios, M. M., & Chiappini, E. (2025). Performance evaluation of the LIOFeron®TB/LTBI IGRA for screening of paediatric LTBI and tuberculosis. European Journal of Pediatrics. https://doi.org/10.1007/s00431-025-05972-6

Vancouver

Della Bella C, Motisi MA, Venturini E, D'Elios S, Asvestopoulou E, Tamborino AM, et al. Performance evaluation of the LIOFeron®TB/LTBI IGRA for screening of paediatric LTBI and tuberculosis. European Journal of Pediatrics. 2025. doi:10.1007/s00431-025-05972-6

BibTeX
@article{DellaBella2025,
  author = {Della Bella, Chiara and Motisi, Marco Antonio and Venturini, Elisabetta and D'Elios, Sofia and Asvestopoulou, Evangelia and Tamborino, Agnese Maria and Galli, Luisa and D'Elios, Mario Milco and Chiappini, Elena},
  title = {Performance evaluation of the LIOFeron®TB/LTBI IGRA for screening of paediatric LTBI and tuberculosis},
  journal = {European Journal of Pediatrics},
  year = {2025},
  doi = {10.1007/s00431-025-05972-6}
}
Kostenlos starten →